Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital

被引:32
|
作者
Aquino-Andrade, Alejandra [1 ]
Merida-Vieyra, Jocelin [1 ]
Arias de la Garza, Eduardo [2 ]
Arzate-Barbosa, Patricia [3 ]
De Colsa Ranero, Agustin [1 ,2 ]
机构
[1] Inst Nacl Pediat, Mol Microbiol Lab, Insurgentes Sur 3700-C, Mexico City 04530, DF, Mexico
[2] Inst Nacl Pediat, Pediat Infect Dis Dept, Mexico City, DF, Mexico
[3] Inst Nacl Pediat, Clin Bacteriol Lab, Mexico City, DF, Mexico
来源
BMC MICROBIOLOGY | 2018年 / 18卷
关键词
Carbapenemase-producing Enterobacteriaceae; Pediatrics; Mexico; NDM-1; KPC-2; OXA-48; OXA-232; METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; RESISTANT ENTEROBACTERIACEAE; GLOBAL DISSEMINATION; TREATMENT OPTIONS; INFECTIONS; SPREAD; NDM-1; EMERGENCE;
D O I
10.1186/s12866-018-1166-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Carbapenemases-producing Enterobacteriaceae (CPE) are a worldwide public health emergency. In Mexico, reports of CPE are limited, particularly in the pediatric population. Here, we describe the clinical, epidemiological, and molecular characteristics of seven consecutive cases in a third-level pediatric hospital in Mexico City over a four-month period during 2016. Results: The Enterobacteriaceae identified were three Escherichia coli strains (producing OXA-232, NDM-1 and KPC-2), two Klebsiella pneumoniae strains (producing KPC-2 and NDM-1), one Klebsiella oxytoca strain producing OXA-48 and one Enterobacter cloacae strain producing NDM-1. The majority of patients had underlying disesases, three were immunocompromised, and three had infections involved the skin and soft tissues. Half patients died as a result of CPE infection. Conclusions: This study represents the first report of E coil ST131-O25b clone producing NDM-1 in Latin America. In addition, this study is the first finding of K oxytoca producing OXA-48 and E. coli producing OXA-232 in Mexican pediatric patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand
    Venanzio, Vella
    Gharbi, Myriam
    Moore, Luke S. P.
    Robotham, Julie
    Davies, Frances
    Brannigan, Eimear
    Galletly, Tracey
    Holmes, Alison H.
    JOURNAL OF INFECTION, 2015, 71 (04) : 493 - 495
  • [12] Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae: A qualitative study
    King, Caroline
    Grandison, Tracyanne
    Cawthorne, Julie
    Currie, Kay
    JOURNAL OF CLINICAL NURSING, 2019, 28 (21-22) : 3890 - 3900
  • [13] Evaluation of effectiveness of carbapenemase-producing Enterobacteriaceae reduction program in a convalescence hospital
    Chan, Nga Han
    Lee, Suet Yi
    Kong, Man Ying
    Chan, Suk Yin
    Lo, Wun Kei
    Lai, Koon Chi
    Tsang, Dominic Ngai Chong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S245 - S246
  • [14] Molecular epidemiology of carbapenemase-producing Enterobacteriaceae infection/colonisation in a hospital in Madrid
    Branas, Patricia
    Gil, Marta
    Villa, Jennifer
    Angeles Orellana, Maria
    Chaves, Fernando
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2018, 36 (02): : 100 - 103
  • [15] Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae
    Marimuthu, Kalisvar
    Ng, Oon Tek
    Cherng, Benjamin Pei Zhi
    Fong, Raymond Kok Choon
    Pada, Surinder Kaur
    De, Partha Pratim
    Ooi, Say Tat
    Smitasin, Nares
    Thoon, Koh Cheng
    Krishnan, Prabha Unny
    Ang, Michelle Lay Teng
    Chan, Douglas Su Gin
    Kwa, Andrea Lay Hoon
    Deepak, Rama Narayana
    Chan, Yu Kit
    Chan, Yvonne Fu Zi
    Huan, Xiaowei
    Linn, Kyaw Zaw
    Tee, Nancy Wen Sim
    Tan, Thean Yen
    Koh, Tse Hsien
    Lin, Raymond Tzer Pin
    Hsu, Li Yang
    Sengupta, Sharmila
    Paterson, David L.
    Perencevich, Eli
    Harbarth, Stephan
    Teo, Jeanette
    Venkatachalam, Indumathi
    Cherng, Benjamin
    Gin, Douglas Chan Su
    Narayana, Deepak Rama
    Pratim, De Partha
    Yang, Hsu Li
    Venkatacha, Indumathi
    Hsien, Koh Tse
    Tee, Nancy
    Tek, Ng Oon
    Tat, Ooi Say
    Fong, Raymond
    Pin, Raymond Lin Tzer
    Yen, Tan Thean
    Cheng, Thoon Koh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)
  • [16] Epidemiology of the carbapenemase-producing Enterobacteriaceae spread in a community acute hospital and a non-acute rehabilitation hospital in Madrid
    Lopez-Dosil, Marcos
    Bischofberge, Cornelia
    Saez, David
    Garcia-Picazo, Luisa
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2017, 30 (06) : 458 - 463
  • [17] Effectiveness of Antiepidemic Measures Aimed to Reduce Carbapenemase-Producing Enterobacteriaceae in the Hospital Environment
    Pawlak, Maria
    Lewtak, Katarzyna
    Nitsch-Osuch, Aneta
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [18] Carbapenemase-producing Enterobacteriaceae in hospital wastewater: a reservoir that may be unrelated to clinical isolates
    White, L.
    Hopkins, K. L.
    Meunier, D.
    Perry, C. L.
    Pike, R.
    Wilkinson, P.
    Pickup, R. W.
    Cheesbrough, J.
    Woodford, N.
    JOURNAL OF HOSPITAL INFECTION, 2016, 93 (02) : 145 - 151
  • [19] Carbapenemase-producing Enterobacteriaceae: a 2-year surveillance in a hospital in Iasi, Romania
    Braun, Sascha D.
    Dorneanu, Olivia S.
    Vremera, Teodora
    Reissig, Annett
    Monecke, Stefan
    Ehricht, Ralf
    FUTURE MICROBIOLOGY, 2016, 11 (03) : 391 - 401
  • [20] Lack of polymyxin resistance among carbapenemase-producing Enterobacteriaceae in a university hospital in China
    Jiang, Xiaofei
    Poirel, Laurent
    Nordmann, Patrice
    INFECTIOUS DISEASES, 2017, 49 (07) : 556 - 557